Two Years of Hard Work Pays Off For Green Pharma as it Becomes a GMP Facility
SAHPRA has awarded Green Pharma GMP certification for its Pretoria facility as the company sets itself up to be a dedicated third party processor in the manufacture of medicines and the packaging of cannabis flower.
New Ugandan Medical Cannabis Organization Launched to Promote Compliance and Market Access
A new organization has been launched in Uganda to promote the development of the medical cannabis sector in an orderly and responsible way. The Uganda Medical Cannabis and Industrial Hemp Cooperative Society (UMCHICS) hopes to organize licensed farmers and promote compliance and market access.
“How is this Right?”: A Mother’s Anguish as SAHPRA Refuses to Renew Son’s Medical Cannabis Epilepsy Treatment
The mother of a medical cannabis patient with severe epilepsy has accused SAHPRA of harming the very patients the regulator exists to protect. Ursula Kendall says it is an outrage that cannabis is freely available for social use, while genuine patients following every legal step are being turned away.
TUT Working with Traditional Healers to Bridge the Divide Between Western and African Medicine
The Tshwane University of Technology is running short learning courses for traditional healers in ethical sourcing, plant medicine and patient care. Part of the course involves the use of cannabis in traditional African medicine.
GES’s Peter Nel: Govt Could Earn Billions from Cannabis if Regulation Caught Up with Reality
South Africa could be the most important cannabis legal markets in the world if regulation were to catch up with reality. GES Lab’s Peter Nel says government could be earning up to R100 billion a year in tax and excise revenue if it played its cards right.
Labat Shareholders Lose Out as Hollard Wins Court Order to Wind Up Former Cannabis Giant
Former cannabis corporate conglomerate Labat looks set to be liquidated after Hollard Insurance won a R20 million claim against it in the Gauteng High Court on 20 October 2026. Shareholders are unlikely to receive any payout as a result.